Log in

Start free trial
Home 5 Clinical Diagnostics Insider 5 CMS Ignores Flawed Processes, Finalizes 2018 PAMA Pricing; Labs Need to Take Immediate Action to Offset Impending Lean Times

CMS Ignores Flawed Processes, Finalizes 2018 PAMA Pricing; Labs Need to Take Immediate Action to Offset Impending Lean Times

by | Dec 4, 2017 | Clinical Diagnostics Insider, Fee Schedules-lir, Fee Schedules-nir, Industry Buzz-lir, Inside the Lab Industry-lir, News at a Glance-lca, News-nir, Reimbursement-dtet, Reimbursement-lca, Reimbursement-lir, Reimbursement-nir, Top of the News-dtet, Top of the News-lir

By Kyle Fetter  bio The final 2018 clinical laboratory fee schedule (CLFS) is out, and it is evident that the argument that the Centers for Medicare & Medicaid Services (CMS) PAMA process was… . . . read more

iStock, ipopba

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article

TRY FOR FREE